(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone

C50H73NO12 — CID 67015115

IUPAC(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
SMILESCCC1/C=C(\C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(OCC(=O)c4ccccc4)C(O)C3)C(C)CCC1=O)C(C)CC2OC
InChIInChI=1S/C50H73NO12/c1-9-36-24-30(2)23-31(3)25-43(59-7)46-44(60-8)27-34(6)50(58,63-46)47(55)48(56)51-22-14-13-17-38(51)49(57)62-45(32(4)18-20-39(36)52)33(5)26-35-19-21-42(40(53)28-35)61-29-41(54)37-15-11-10-12-16-37/h10-12,15-16,24,26,31-32,34-36,38,40,42-46,53,58H,9,13-14,17-23,25,27-29H2,1-8H3/b30-24+,33-26?
InChIKeyGUGPFDFQAIBGDK-MSYUXUBASA-N
MW880.13 g/mol
LogP6.76
Rot. Bonds9

About (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone

(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone (PubChem CID 67015115) has the molecular formula C50H73NO12 and a molecular weight of 880.13 g/mol. Its IUPAC name is (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone.

Molecular Properties

Compound Name(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
PubChem CID67015115
Molecular FormulaC50H73NO12
Molecular Weight880.13 g/mol
Exact Mass879.51
IUPAC Name(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
SMILESCCC1/C=C(\C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(OCC(=O)c4ccccc4)C(O)C3)C(C)CCC1=O)C(C)CC2OC
InChIInChI=1S/C50H73NO12/c1-9-36-24-30(2)23-31(3)25-43(59-7)46-44(60-8)27-34(6)50(58,63-46)47(55)48(56)51-22-14-13-17-38(51)49(57)62-45(32(4)18-20-39(36)52)33(5)26-35-19-21-42(40(53)28-35)61-29-41(54)37-15-11-10-12-16-37/h10-12,15-16,24,26,31-32,34-36,38,40,42-46,53,58H,9,13-14,17-23,25,27-29H2,1-8H3/b30-24+,33-26?
InChIKeyGUGPFDFQAIBGDK-MSYUXUBASA-N
XLogP6.76
TPSA175.20 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms63
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500880.13
LogP ≤ 56.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone?
The IUPAC name of (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone (CID 67015115) is (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone.
What is the SMILES notation for (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone?
The canonical SMILES for (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone is CCC1/C=C(\C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(OCC(=O)c4ccccc4)C(O)C3)C(C)CCC1=O)C(C)CC2OC.
What is the InChIKey of (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone?
The InChIKey is GUGPFDFQAIBGDK-MSYUXUBASA-N. The full InChI is InChI=1S/C50H73NO12/c1-9-36-24-30(2)23-31(3)25-43(59-7)46-44(60-8)27-34(6)50(58,63-46)47(55)48(56)51-22-14-13-17-38(51)49(57)62-45(32(4)18-20-39(36)52)33(5)26-35-19-21-42(40(53)28-35)61-29-41(54)37-15-11-10-12-16-37/h10-12,15-16,24,26,31-32,34-36,38,40,42-46,53,58H,9,13-14,17-23,25,27-29H2,1-8H3/b30-24+,33-26?.
What are the key properties of (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone?
(18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone has a molecular weight of 880.13 g/mol, XLogP of 6.76, 9 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (18E)-17-ethyl-1-hydroxy-12-[1-(3-hydroxy-4-phenacyloxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone is sourced from PubChem (CID 67015115), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).